{"id":"NCT02600819","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis","officialTitle":"A Phase 3b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Subjects on Chronic Hemodialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-14","primaryCompletion":"2017-09-29","completion":"2019-10-15","firstPosted":"2015-11-09","resultsPosted":"2018-10-16","lastUpdate":"2020-11-05"},"enrollment":55,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV-1 Infection"],"interventions":[{"type":"DRUG","name":"E/C/F/TAF","otherNames":["Genvoya®"]},{"type":"DRUG","name":"B/F/TAF","otherNames":["Biktarvy®"]}],"arms":[{"label":"E/C/F/TAF","type":"EXPERIMENTAL"},{"label":"Open-Label Rollover Extension B/F/TAF","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the safety and tolerability of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) in human immunodeficiency virus (HIV-1) infected adults with end-stage renal disease (ESRD) on chronic hemodialysis (HD).","primaryOutcome":{"measure":"GEN Phase: Percentage of Participants Experiencing Treatment-Emergent Grade 3 or Higher Adverse Events Up to Week 48","timeFrame":"First Dose Date Up to Week 48","effectByArm":[{"arm":"E/C/F/TAF (GEN Phase)","deltaMin":32.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":26,"countries":["United States","Austria","France","Germany"]},"refs":{"pmids":["30555051"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":55},"commonTop":["Nausea","Cough","Hyperkalaemia","Oedema peripheral","Pain in extremity"]}}